Oxisopred

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H28O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0C39YBM73T, chemically known as 11beta,17,21-trihydroxy-b-homo-a-norpregn-1-ene-3,6,20-trione but generally known as oxisopred, which bears US NIH Compound Identifier 3047809. European Medicines Agency schedules Oxisopred in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09538MIG. The term OXISOPRED is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). OXISOPRED is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxisopred under HS 29372900 and SITC 54153. As of Q4 2014, OXISOPRED remains the US FDA Preferred Term for this commodity. Oxisopred bears US NLM identifiers UMLS ID C1882242 and NCI Concept Code C66272. SMILES: OC1(C2(C(C3C(C(O)C2)C2(C(C(=O)CC3)C(=O)C=C2)C)CC1)C)C(=O)OC.